Ryan T Sullivan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ryan T Sullivan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ryan T Sullivan. Ryan T Sullivan is General Counsel in INTERCEPT PHARMACEUTICALS INC ($ICPT) and General Counsel and Secretary in INTERCEPT PHARMACEUTICALS, INC. ($ICPT) and VP, General Counsel & Secr. in Warner Chilcott plc ($WCRX) and EVP and General Counsel in Anacor Pharmaceuticals, Inc. ($ANAC) and Sr. VP and General Counsel in Anacor Pharmaceuticals, Inc. ($ANAC).
Latest Insider Trading Transactions of Ryan T Sullivan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAC, ICPT, WCRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16 2020 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 37.87 | 493 | 18,670 | 24,708 | 25.2 K to 24.7 K (-1.96 %) |
| Aug 14 2020 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 51.86 | 493 | 25,567 | 25,201 | 25.7 K to 25.2 K (-1.92 %) |
| May 14 2020 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 85.08 | 493 | 41,944 | 25,694 | 26.2 K to 25.7 K (-1.88 %) |
| Feb 14 2020 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 94.69 | 493 | 46,682 | 26,187 | 26.7 K to 26.2 K (-1.85 %) |
| Jan 27 2020 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Option Exercise | A | 99.66 | 9,200 | 916,872 | 9,200 | |
| Jan 27 2020 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Grant | A | 0.00 | 5,600 | 0 | 26,680 | 21.1 K to 26.7 K (+26.57 %) |
| Jan 03 2020 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 123.92 | 809 | 100,251 | 21,080 | 21.9 K to 21.1 K (-3.70 %) |
| Nov 19 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Option Exercise | M | 53.41 | 8,325 | 444,638 | 26,475 | |
| Nov 19 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Option Exercise | M | 53.41 | 8,325 | 444,638 | 26,475 | |
| Nov 19 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Sell | S | 85.00 | 3,829 | 325,465 | 21,889 | 25.7 K to 21.9 K (-14.89 %) |
| Nov 19 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Sell | S | 85.00 | 3,829 | 325,465 | 21,889 | 25.7 K to 21.9 K (-14.89 %) |
| Nov 19 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Sell | S | 85.00 | 8,325 | 707,625 | 25,718 | 34 K to 25.7 K (-24.45 %) |
| Nov 19 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Sell | S | 85.00 | 8,325 | 707,625 | 25,718 | 34 K to 25.7 K (-24.45 %) |
| Nov 19 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Buy | M | 53.41 | 8,325 | 444,638 | 34,043 | 25.7 K to 34 K (+32.37 %) |
| Nov 19 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Buy | M | 53.41 | 8,325 | 444,638 | 34,043 | 25.7 K to 34 K (+32.37 %) |
| Nov 15 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Option Exercise | M | 53.41 | 500 | 26,705 | 34,800 | |
| Nov 15 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 83.92 | 711 | 59,667 | 25,718 | 26.4 K to 25.7 K (-2.69 %) |
| Nov 15 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Sell | S | 85.00 | 500 | 42,500 | 26,429 | 26.9 K to 26.4 K (-1.86 %) |
| Nov 15 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Buy | M | 53.41 | 500 | 26,705 | 26,929 | 26.4 K to 26.9 K (+1.89 %) |
| Aug 14 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 66.03 | 689 | 45,495 | 26,429 | 27.1 K to 26.4 K (-2.54 %) |
| May 14 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 83.73 | 711 | 59,532 | 27,118 | 27.8 K to 27.1 K (-2.55 %) |
| Feb 14 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Payment of Exercise | F | 110.35 | 1,971 | 217,500 | 27,829 | 29.8 K to 27.8 K (-6.61 %) |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Option Exercise | A | 110.80 | 10,700 | 1,185,560 | 10,700 | |
| Jan 18 2019 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel and ... | Grant | A | 0.00 | 6,600 | 0 | 29,800 | 23.2 K to 29.8 K (+28.45 %) |
| Feb 15 2018 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel | Option Exercise | A | 53.41 | 35,300 | 1,885,373 | 35,300 | |
| Feb 15 2018 | ICPT | INTERCEPT PHARMACE ... | Sullivan Ryan T | General Counsel | Grant | A | 0.00 | 23,200 | 0 | 23,200 | 0 to 23.2 K |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 78.91 | 31,623 | 2,495,371 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 78.91 | 31,623 | 2,495,371 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 37.81 | 24,360 | 921,052 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 15.30 | 30,000 | 459,000 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 15.30 | 30,000 | 459,000 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,250 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,250 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | D | 0.00 | 6,350 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Sell | D | 99.25 | 30,132 | 2,990,601 | 0 | 30.1 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Sell | D | 99.25 | 30,132 | 2,990,601 | 0 | 30.1 K to 0 (-100.00 %) |
| Apr 29 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Sell | S | 66.33 | 3,125 | 207,281 | 30,132 | 33.3 K to 30.1 K (-9.40 %) |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | A | 0.00 | 6,250 | 0 | 6,250 | |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Option Exercise | A | 78.91 | 31,623 | 2,495,371 | 31,623 | |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | EVP and General Cou ... | Grant | A | 0.00 | 6,250 | 0 | 33,257 | 27 K to 33.3 K (+23.14 %) |
| Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 112.69 | 200 | 22,537 | 27,007 | 27.2 K to 27 K (-0.74 %) |
| Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 112.05 | 333 | 37,311 | 27,207 | 27.5 K to 27.2 K (-1.21 %) |
| Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 110.44 | 200 | 22,087 | 27,540 | 27.7 K to 27.5 K (-0.72 %) |
| Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Option Exercise | M | 15.30 | 10,000 | 153,000 | 30,000 | |
| Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 111.03 | 4,000 | 444,102 | 27,740 | 31.7 K to 27.7 K (-12.60 %) |
| Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 110.25 | 4,900 | 540,209 | 31,740 | 36.6 K to 31.7 K (-13.37 %) |
| Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 108.90 | 1,100 | 119,794 | 36,640 | 37.7 K to 36.6 K (-2.91 %) |
| Dec 11 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Buy | M | 15.30 | 10,000 | 153,000 | 37,740 | 27.7 K to 37.7 K (+36.05 %) |
| May 01 2015 | ANAC | Anacor Pharmaceuti ... | Sullivan Ryan T | Sr. VP and General ... | Sell | S | 53.61 | 3,125 | 167,531 | 27,740 | 30.9 K to 27.7 K (-10.12 %) |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Option Exercise | D | 14.31 | 28,860 | 412,987 | 0 | |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Option Exercise | D | 13.35 | 15,730 | 209,996 | 0 | |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Option Exercise | D | 21.49 | 8,990 | 193,195 | 0 | |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Option Exercise | D | 16.06 | 6,610 | 106,157 | 0 | |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Option Exercise | D | 1.88 | 1,065 | 2,002 | 0 | |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Option Exercise | D | 2.02 | 2,193 | 4,430 | 0 | |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Option Exercise | D | 0.00 | 8,170 | 0 | 0 | |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Sell | D | 0.00 | 18,040 | 0 | 0 | 18 K to 0 (-100.00 %) |
| Oct 01 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Sell | D | 0.00 | 8,420 | 0 | 18,040 | 26.5 K to 18 K (-31.82 %) |
| Jul 02 2013 | WCRX | Warner Chilcott pl ... | Sullivan Ryan T | VP, General Counsel ... | Sell | S | 19.88 | 169 | 3,360 | 26,460 | 26.6 K to 26.5 K (-0.63 %) |
Page: 1